Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
SRUUF Stock Summary
In the News

Kazatomprom: A Top Choice For Uranium Exposure
2022 was a record year for Kazatomprom, with revenues up around 45% on the back of rising uranium prices, and profits doubling. At the same time, production costs also rose, with cash cost and AISC up, respectively, 16% and 28%, as a result of inflationary pressures and logistical challenges.

Sprott Physical Uranium: The Good News Just Keeps Coming
SPUT is trading again at a premium, signaling that interest from financial speculators is picking up. Uranium demand remains strong due to heightened energy security concerns and net-zero emissions targets.

Buy 9% Discounted Uranium With The Sprott Physical Uranium Trust
The Uranium bull market is alive and well, despite the macroeconomic turmoil. The Sprott Physical Uranium Trust has the potential to corner the U3O8 market.

URNM Vs. SRUUF: The Best Way To Play The Uranium Bullish Case
I am diving into the uranium industry based on relevant reports from Citi, Morgan Stanley, and Bank of America. Analysis of available trends and data shows that this industry has impressive growth potential.

Uranium Keeps Getting Warmer. Our Top Picks - BHP, Cameco And SRUUF
Our recent 'Buy' notes in the uranium sector have proven righteous, in a very difficult overall market environment. We remain bullish on the uranium sector as a whole and are long the sector in staff personal accounts.

The Case for a Nuclear Bull Market Remains Strong
In the latest Sprott Uranium Report, Sprott Asset Management CEO John Ciampaglia took a look at how the Sprott Physical Uranium Trust (SPUT, TSX: U.U ($US); U.UN ($CA)) has helped modernize the physical uranium market in just over a year from its July 2021 inception. Uranium had been bogged down in a nine-year bear market.

Sprott Physical Uranium Trust: All Stars Are Aligned For The Uranium Bull Market
Even after last year's run-up, uranium is still trading below the production cost of new marginal supply, in an undersupplied market. Add to the supply/demand imbalance: inflation, geopolitical tensions, the green energy transition, the energy crisis, utilities returning to the market, and financial speculation. The outlook could not be more bullish.

Climate Catastrophe Makes Uranium Crucial
In talking about climate change, UN Secretary General António Guterres told leaders from 40 countries, “half of humanity is in the danger zone from floods, droughts, extreme storms, and wildfires. No nation is immune.

Sprott Physical Uranium Trust: Too Cheap To Ignore
Uranium's recent price drop is due to Fed monetary tightening, not uranium-specific factors. Elevated risks brought about by the Ukrainian war have lessened.

Buy Discounted Uranium With The Sprott Physical Uranium Trust & Yellow Cake
The Uranium Bull Market is set to continue as future demand outstrips future supply. Sprott Physical Uranium Trust & Yellow Cake are trading at substantial discounts to their NAV.
SRUUF Financial details
SRUUF Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-02-28 | 2019-02-28 | 2020-02-29 | 2021-02-28 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0.01 | 0.01 | 0.02 | 0 | |
Net income per share | -0.46 | 1.9 | -1.78 | 1.51 | 5.87 | |
Operating cash flow per share | -0.06 | -0.07 | -0.05 | -0.06 | -3.7 | |
Free cash flow per share | -0.49 | -0.29 | -0.12 | -0.08 | -17.08 | |
Cash per share | 0.06 | 0.06 | 0.03 | 0.02 | 0.3 | |
Book value per share | 5.78 | 7.3 | 6.46 | 7.17 | 42.21 | |
Tangible book value per share | 5.78 | 7.3 | 6.46 | 7.17 | 42.21 | |
Share holders equity per share | 5.78 | 7.3 | 6.46 | 7.17 | 42.21 | |
Interest debt per share | 0 | 0 | 0 | 0 | -6.28 | |
Market cap | 746.45M | 842.03M | 853.39M | 798.16M | 1.08B | |
Enterprise value | 742.67M | 837.61M | 851.03M | 796.88M | 1.06B | |
P/E ratio | -25.59 | 6.49 | -6.95 | 7.76 | 2.7 | |
Price to sales ratio | 4.26K | 2.05K | 2.11K | 662.14 | 0 | |
POCF ratio | -214.53 | -187.53 | -238.78 | -202.64 | -4.28 | |
PFCF ratio | -24.19 | -42.49 | -106.18 | -145.79 | -0.93 | |
P/B Ratio | 2.06 | 1.69 | 1.91 | 1.63 | 0.38 | |
PTB ratio | 2.06 | 1.69 | 1.91 | 1.63 | 0.38 | |
EV to sales | 4.24K | 2.04K | 2.1K | 661.08 | 0 | |
Enterprise value over EBITDA | -25.46 | 6.45 | 24.14 | -20.16 | -4.37 | |
EV to operating cash flow | -213.44 | -186.55 | -238.12 | -202.31 | -4.2 | |
EV to free cash flow | -24.07 | -42.27 | -105.89 | -145.56 | -0.91 | |
Earnings yield | -0.04 | 0.15 | -0.14 | 0.13 | 0.37 | |
Free cash flow yield | -0.04 | -0.02 | -0.01 | -0.01 | -1.08 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0.13 | -0.03 | -0.07 | 0.03 | 0.08 | |
Current ratio | 4.18 | 6.76 | 5.1 | 4.95 | 1.78 | |
Interest coverage | 0 | 0 | 0 | 0 | 1.07 | |
Income quality | 0.12 | -0.03 | 0.08 | -0.12 | -1.36 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 23.07 | 11.2 | 11.62 | 4.25 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 7.87 | 3.41 | 1.25 | 0.39 | 3.62 | |
Capex to revenue | -156.1 | -37.25 | -11.03 | -1.27 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.77 | 17.67 | 16.08 | 15.61 | 74.69 | |
ROIC | -0.01 | -0.01 | 0.22 | -0.26 | -0.35 | |
Return on tangible assets | -0.08 | 0.26 | -0.28 | 0.21 | 0.14 | |
Graham Net | 0.08 | 0.06 | 0.02 | 0.01 | 0.14 | |
Working capital | 5.93M | 4.32M | 3.07M | 2.1M | 12.29M | |
Tangible asset value | 362.69M | 498.82M | 445.7M | 488.71M | 2.88B | |
Net current asset value | 5.93M | 4.32M | 3.07M | 2.1M | 12.29M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 2.19M | 2.33M | 371.48K | 68.7K | 3.22M | |
Average payables | 1.6M | 1.31M | 748.21K | 640.03K | 6.47M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 8.34K | 578.87 | 81.49 | 14.26 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.04 | 0.63 | 4.48 | 25.6 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.08 | 0.26 | -0.28 | 0.21 | 0.14 | |
Capex per share | -0.44 | -0.22 | -0.06 | -0.02 | -13.39 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2020-11-30 | 2021-02-28 | 2021-05-31 | 2022-06-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -1.03 | 0 | 1.25 | 0 | 0 | |
Operating cash flow per share | -0.01 | 0 | -0.01 | 0 | 0 | |
Free cash flow per share | -0.01 | 0 | -0.01 | 0 | 0 | |
Cash per share | 0.04 | 0 | 0.95 | 0 | 0 | |
Book value per share | 7.58 | 0 | 8.93 | 0 | 0 | |
Tangible book value per share | 7.58 | 0 | 8.93 | 0 | 0 | |
Share holders equity per share | 7.58 | 0 | 8.93 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 815.18M | 0 | 759.46M | 0 | 0 | |
Enterprise value | 812.23M | -1.28M | 695.19M | -225.44M | -20.53M | |
P/E ratio | -2.92 | 0 | 2.23 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 7.34K | 0 | 0 | |
POCF ratio | -1.47K | 0 | -815.46 | 0 | 0 | |
PFCF ratio | -1.44K | 0 | -815.46 | 0 | 0 | |
P/B Ratio | 1.58 | 0 | 1.25 | 0 | 0 | |
PTB ratio | 1.58 | 0 | 1.25 | 0 | 0 | |
EV to sales | 0 | -57.08 | 6.72K | 0 | 0 | |
Enterprise value over EBITDA | 37.21 | -0.04 | -22.33 | 0 | 0 | |
EV to operating cash flow | -1.46K | 0.74 | -746.45 | 0 | 0 | |
EV to free cash flow | -1.43K | 0.72 | -746.45 | 0 | 0 | |
Earnings yield | -0.09 | 0 | 0.11 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.14 | -0.04 | 2.06 | 0 | 0 | |
Current ratio | 4.34 | 4.95 | 28.21 | 1.39 | 1.78 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0.02 | 0.05 | -0.03 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 73.7 | 21.34 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.02 | 0.02 | 0 | 0 | 0 | |
Capex to revenue | 0 | -1.27 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 13.24 | 0 | 15.86 | 0 | 0 | |
ROIC | 0.12 | 0.18 | -0.21 | 0 | 0 | |
Return on tangible assets | -0.14 | -0.19 | 0.14 | 0 | 0 | |
Graham Net | 0.03 | 0 | 0.91 | 0 | 0 | |
Working capital | 3.48M | 2.1M | 63.27M | 65.44M | 12.29M | |
Tangible asset value | 514.95M | 488.71M | 606.01M | 2.93B | 2.88B | |
Net current asset value | 3.48M | 2.1M | 63.27M | 65.44M | 12.29M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 89.18K | 136K | 172.63K | 0 | 0 | |
Average payables | 729.7K | 788.22K | 1.16M | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 727.79 | 142.27 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0.12 | 0.63 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.14 | -0.19 | 0.14 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SRUUF Frequently Asked Questions
What is Sprott Physical Uranium Trust Fund stock symbol ?
Sprott Physical Uranium Trust Fund is a CA stock , located in Toronto of On and trading under the symbol SRUUF
What is Sprott Physical Uranium Trust Fund stock quote today ?
Sprott Physical Uranium Trust Fund stock price is $13.06 today.
Is Sprott Physical Uranium Trust Fund stock public?
Yes, Sprott Physical Uranium Trust Fund is a publicly traded company.